Upload
sanket-golechha
View
248
Download
3
Tags:
Embed Size (px)
Citation preview
Capstone Research by: Sanket Golechha – MJAN14GLM38
Logistics and Supply Chain in Pharmaceutical Industry
Logistics and Supply Chain in Pharmaceutical Industry
Agenda
1. Introduction
2. Research Objectives
3. Research Framework
4. Research Findings
2
5. Recommendations
6. Limitations of the study
7. Future Scope
Pharmaceutical Industry – Complex Supply Chain
Various forms of products
Product specific handling requirements
Necessity – Presence across the World
Involvement of various regulatory bodies
Security concern to avoid counterfeit drugs from entering the supply chain
One of the fastest growing industry in the world
3 Logistics and Supply Chain in Pharmaceutical Industry
Introduction
To study the supply chain in Pharmaceutical Industry of Singapore
To study the regulations and security involved in the supply chain to eliminate counterfeit drugs from the Industry
To suggest recommendations for the Pharmaceutical industry of Singapore to make their supply chain more secured
Logistics and Supply Chain in Pharmaceutical Industry
Proposed Objectives
4
Logistics and Supply Chain in Pharmaceutical Industry
Research Framework
5
Pharmaceutical Industry
Business Environment
Logistics Environment
Supply Chain
Product Flow
Information Flow
Money Flow
Complexity
Network Criticality
Counterfeity
Cold Chain
Reverse Logistics
Regulations
Legality
Laws of the land
Regulatory Bodies
Singapore
Industry Expert
Mr. Kalaiarasan – Supply Chain Head of Asia Pacific, Middle East, African countries and Greater China regions; Novartis Pharmaceuticals
Pharmaceutical Academician
Mr. Deepak Srideshmukh, professional trainer for various practices of Pharmaceutical Industry
Logistics and Supply Chain in Pharmaceutical Industry
Primary Research
6
Logistics and Supply Chain in Pharmaceutical Industry
Supply Chain – Novartis Pharma.
7
Manufacturers•Manufacturing plants of Europe and USA
Distributors cum
Consignment Agents
• Zuellig Pharmaceuticals, Singapore (3PL)
Retailer
•Hospital Pharmacies, Watsons Pharmacy, etc
Product Flow
Manufacturing houses
Channels and players involved
Information Flow
IT Involvement
Money Flow
Pricing and Credit Period
Returns/Reverse Logistics
Function of Time
Lead Time, Inventory Turnover
Reverse logistics
Expiry, Damaged, Recalls
Logistics and Supply Chain in Pharmaceutical Industry
Supply Chain – Novartis Pharma.
8
Categories of counterfeit products,
Products that have
no active ingredient
wrong/different ingredients than what is mentioned
incorrect quantities of the active ingredient as mentioned
right ingredients in right quantities but fake packaging
copied from the original product
Impurities/contaminants at unreasonable level
9 Logistics and Supply Chain in Pharmaceutical Industry
Counterfeit Drugs
10 Logistics and Supply Chain in Pharmaceutical Industry
Counterfeit Drugs entering the SC
Source: Finlay, 2012
HSA – Health and Sciences Authority of Singapore
National Pharmaceutical Administration
Centre for Drug Evaluation
Product Registration Department
Institute of Science and Forensic Medicine
Licensing
Manufacturer’s, Product’s, Distributor’s, Importer’s
Certificate to Export
Collaborations
WHO, FDA, EMA, etc.
Taxation
Import Duty – 0% and GST – 7%11 Logistics and Supply Chain in
Pharmaceutical Industry
Regulations in Singapore
Source: HAS Singapore, 2012
Network Design
Presence all over the world
Life of the drug
Inventory Management and Material Handling
Large number of Stock Keeping Units
Cold Chain maintenance
Temperature and environment sensitive drugs
High capital investment
Awareness in smaller countries
Reverse Logistics
Breakage, Expiry and Recalls
Regulations to destroy the product
Logistics and Supply Chain in Pharmaceutical Industry
Challenges and Complexities
12
IT involvement
Levels of IT involvement
Right upgradation at the right time
Application of IT in the system
Logistics and Supply Chain in Pharmaceutical Industry
Challenges and Complexities contd…
13
Source: Frost and Sullivan, 2012
Accountability and Traceability through Track and Trace Technology
Serialization in products
Authentic coding with all details
Track the network the drug has travelled
International Collaboration and Cooperation
Centralized database
Collaboration between drug regulatory bodies
Cooperation between International Investigation agencies for making the industry secure
Logistics and Supply Chain in Pharmaceutical Industry
Recommendations
14
Vigilant Pharmacists
Details at POS on and the trends and pattern in particular product range
Destroy empty boxes and used containers
Inform the company in case of any suspicious activity
Educating Consumers and Creating Awareness
Importance of authentic drugs
Make consumers aware about their international collaborations and initiatives for their betterment and safety
Logistics and Supply Chain in Pharmaceutical Industry
Recommendations contd…
15
Collection of data and information that is considered confidential by companies or regulatory bodies
Finding industry experts and getting appointment within the stipulated time
Lack of connect between the industry experts and students due to cultural and language differences
16 Logistics and Supply Chain in Pharmaceutical Industry
Limitations of Study
This study could be extended to the role of Third party logistics Companies and their operations
Supply Chain of other ASEAN countries could be studied
Innovative supply chain involving Postponement could be studied
17 Logistics and Supply Chain in Pharmaceutical Industry
Future Scope
Business Environment of Singapore
Demography
• Population, Area, Population Growth rate, etc
Economic Environment
• GDP, Growth rate, Inflation, Labour Force, etc
Logistics Environment
• Major airports, ports, capacities, market leaders
Rankings
Singapore
• #1 Logistics Hub in the World (World Bank, 2013)
• Connection with 275 cities in 65 countries across the globe
19 Logistics and Supply Chain in Pharmaceutical Industry
Literature Review
Source: Singapore Government, 2014
Pharmaceutical Industry
Total revenue from prescription drugs was $954 Billion in 2012 (Pharmaceutical Research and Manufacturers, 2013)
Singapore
• Growth of 4.9% in 2013 to reach a value of $0.6 Billion
• GlaxoSmithKline Plc leading player with 7.6% market share
20 Logistics and Supply Chain in Pharmaceutical Industry
Literature Review contd…
Source: MarketLine Industry Profile, 2014
21 Logistics and Supply Chain in Pharmaceutical Industry
Distribution Models
Source: BCI Global, 2014
22 Logistics and Supply Chain in Pharmaceutical Industry
IT Adoption Stages
Source: BCI Global, 2014
Setup that automates the entire organization
Integrated enterprise application such as Business Intelligence
Solutions integrating multiple functional areas, like ERP
Department Specific Solution
Level 4
Level 3
Level 2
Level 1
Secondary Research
To read Books, Journals, Reports and Articles onPharmaceutical Industry’s
• Performances and Trends
• Best practices by various companies to make theirsupply chain efficient
• Laws of the land and regulations by the governingbodies
• Technologies adopted to eliminate counterfeit drugs
• Logistics involved in the Supply Chain
23 Logistics and Supply Chain in Pharmaceutical Industry
Research Methodology
Primary Research
Interview Academic expert on
• Handling the complexity in Supply Chain
• Ways to make the supply chain efficient with productspecific requirements
Interview Industry expert on
• Processes followed by their company in the supplychain
• Methods adopted to eliminate counterfeit drugs fromthe supply chain
• System to meet the regulations by the governingauthorities
24 Logistics and Supply Chain in Pharmaceutical Industry
Research Methodology contd…
Logistics and Supply Chain in Pharmaceutical Industry
Milestones
1st Dec – 15th Dec ’14• Report submission• Final Presentation
1st Nov – 31st Nov ’14• Primary Research• Secondary Research
10th Oct – 30th Oct ‘14• Literature Review• Mid Review Presentation• Secondary Research
6th Sept – 10th Oct ’14• Research Topic• Proposal Presentation• Literature Review
Final Presentation
Primary Research
Mid Review
Proposal for the Topic
25